EP Biocomposites (BOM:543595) Beneish M-Score: -2.22 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543595 EP Biocomposites Ltd BOM:543595
76 GF Score
Price ₹106.00
GF Value ₹201.91
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is EP Biocomposites Beneish M-Score?

EP Biocomposites BOM:543595 76 Beneish M-Score is -2.22 as of Aug. 02, 2026. GuruFocus rates BOM:543595 with a GF Score™ of 76/100 and a GF Value™ of ₹201.91 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,696 Construction companies, EP Biocomposites ranks worse than 67.33% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.22 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for EP Biocomposites's Beneish M-Score or its related term are showing as below:

BOM:543595' s Beneish M-Score Range Over the Past 10 Years
Min: -2.22   Med: -1.21   Max: 5.23
Current: -2.22

During the past 8 years, the highest Beneish M-Score of EP Biocomposites was 5.23. The lowest was -2.22. And the median was -1.21.


EP Biocomposites Beneish M-Score Historical Data

* Premium members only.

The historical data trend for EP Biocomposites's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EP Biocomposites Beneish M-Score Chart

EP Biocomposites Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial 5.23 -0.88 -1.21 -1.91 -2.22

EP Biocomposites Semi-Annual Data
Mar19 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.21 0.00 -1.91 0.00 -2.22

BOM:543595 vs TT, JCI, CARR: Beneish M-Score Comparison

For the Building Products & Equipment subindustry, EP Biocomposites's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EP Biocomposites Beneish M-Score vs Construction Industry

For the Construction industry and Industrials sector, EP Biocomposites's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where EP Biocomposites's Beneish M-Score falls into.


BOM:543595
76GF Score
EP Biocomposites Ltd BOM:543595
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EP Biocomposites Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of EP Biocomposites for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9826+0.528 * 0.9757+0.404 * 0.8701+0.892 * 1.1361+0.115 * 2.445
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.028353-0.327 * 0.9692
=-2.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹121.2 Mil.
Revenue was ₹136.4 Mil.
Gross Profit was ₹49.9 Mil.
Total Current Assets was ₹157.4 Mil.
Total Assets was ₹187.3 Mil.
Property, Plant and Equipment(Net PPE) was ₹8.5 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1.0 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0.0 Mil.
Total Current Liabilities was ₹47.1 Mil.
Long-Term Debt & Capital Lease Obligation was ₹18.7 Mil.
Net Income was ₹14.6 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹19.9 Mil.
Total Receivables was ₹108.6 Mil.
Revenue was ₹120.1 Mil.
Gross Profit was ₹42.9 Mil.
Total Current Assets was ₹141.1 Mil.
Total Assets was ₹166.3 Mil.
Property, Plant and Equipment(Net PPE) was ₹3.2 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹1.1 Mil.
Selling, General, & Admin. Expense(SGA) was ₹3.6 Mil.
Total Current Liabilities was ₹35.8 Mil.
Long-Term Debt & Capital Lease Obligation was ₹24.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(121.196 / 136.398) / (108.568 / 120.062)
=0.888547 / 0.904266
=0.9826

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(42.872 / 120.062) / (49.919 / 136.398)
=0.357082 / 0.36598
=0.9757

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (157.353 + 8.459) / 187.314) / (1 - (141.145 + 3.185) / 166.266)
=0.114791 / 0.131933
=0.8701

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=136.398 / 120.062
=1.1361

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.125 / (1.125 + 3.185)) / (1.011 / (1.011 + 8.459))
=0.261021 / 0.106758
=2.445

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 136.398) / (3.648 / 120.062)
=0 / 0.030384
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((18.696 + 47.119) / 187.314) / ((24.515 + 35.761) / 166.266)
=0.351362 / 0.362528
=0.9692

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(14.583 - 0 - 19.894) / 187.314
=-0.028353

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

EP Biocomposites has a M-score of -2.22 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.22 mean?
EP Biocomposites (BOM:543595) has a Beneish M-Score of -2.22 as of Aug. 02, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on EP Biocomposites and its competitors. According to the industry distribution chart, EP Biocomposites ranks #1142 out of 1696 companies in the Construction industry, placing it in the top 67.3%.
Is EP Biocomposites' Beneish M-Score too high?
EP Biocomposites' current Beneish M-Score is -2.22. Based on the distribution chart, EP Biocomposites ranks #1142 out of 1696 companies in the Construction industry, which is below the industry midpoint. Overall, EP Biocomposites has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EP Biocomposites' Beneish M-Score compare to TT and JCI?
According to the Construction industry distribution chart, EP Biocomposites ranks #1142 out of 1696 companies for Beneish M-Score. This places EP Biocomposites in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Construction company?
A good Beneish M-Score depends on the Construction industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on EP Biocomposites and its competitors. EP Biocomposites's current Beneish M-Score is -2.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EP Biocomposites stock overvalued right now?
Based on GuruFocus' analysis, EP Biocomposites (BOM:543595) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹201.91, compared to a current price of ₹106.00 — trading 47.5% below its estimated fair value. The current Beneish M-Score is -2.22. EP Biocomposites' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For EP Biocomposites (BOM:543595), the current Beneish M-Score is -2.22 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EP Biocomposites (BOM:543595) Overvalued in 2026?

Based on GuruFocus' analysis, EP Biocomposites stock appears to be undervalued. The current stock price of ₹106.00 is trading 47.5% below its estimated GF Value™ of ₹201.91. GuruFocus considers EP Biocomposites to be Significantly Undervalued.

Key valuation signals for BOM:543595:

  • Beneish M-Score: -2.22
  • GF Value™: ₹201.91 vs. price of ₹106.00 (47.5% below fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the BOM:543595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EP Biocomposites Business Description

Address 1st Floor, B.R. Commercial Centre, Opposite Parade Grounds, Campal, Panaji, GA, IND, 403001
EP Biocomposites Ltd is the manufacturer and supplier of fibre reinforced polymers products such as door shutters, frames, Biodigestor Tanks, Bio toilets and allied products for construction and Industrial applications. The company focus on giving sanitation solutions to those who do not have access to toilets, as well as to those who have toilets but face trouble treating and managing the waste through septic tanks. The company also provides sanitation infrastructure and human waste management solutions and services, involving simple bio-digester technology licensed from the Defence Research and Development Organisation (DRDO) and Industry Interface and Technology Management, operating under the aegis of DRDO, Ministry of Defence, Government of India.
76GF Score

Get the complete analysis for BOM:543595

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹106.00
Price
₹201.91
GF Value